CD79A and HIV infectious disease: Notably, we observed lower serum anti-spike IgA and neutralizing antibody levels in HIV-1-infected subjects after adjustment for age, gender, prime-boost interval, and time after second vaccine dose, denoting a negative effect of the HIV infection on BNT162b2 mRNA-induced humoral responses.